SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals submits certificate

25 Jul 2019 Evaluate

SMS Pharmaceuticals has informed about submission of certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2019. 

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

381.10 2.95 (0.78%)
25-Jun-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1879.00
Dr. Reddys Labs. 1361.70
Cipla 1444.00
Zydus Lifesciences 1110.55
Lupin 2374.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: